OBJECTIVE: Widespread implementation of rigorous, systematic endoscopic bio
psy protocols for patients with Barrett's esophagus may be hindered by conc
erns about their safety. This report describes the safety experience of a l
arge series of patients with gastroesophageal reflux disease and Barrett's
esophagus who underwent such procedures.
METHODS: Patients in the Seattle Barrett's Esophagus Project undergo biopsy
surveillance in a research-based clinical setting, using large channel end
oscopes and "jumbo" biopsy forceps. After visual inspection, multiple biops
ies are obtained from lesions and at 1- to 2-cm intervals throughout the Ba
rrett's esophageal segment.
RESULTS: From 1983 to 1997, 1,458 consecutive endoscopies were performed on
705 patients and 50,833 biopsies (average, 35; maximum, 120 per procedure)
were taken. Procedures lasted from 15 to 90 min during which one to two bi
opsies were obtained per minute. Eleven patients experienced 18 significant
adverse events, five of which led to overnight hospitalizations: two for b
leeding attributed to concomitant esophageal stricture dilation; two for ca
rdiac dysrhythmias: and one for respiratory arrest. Events managed In outpa
tient settings included chest pain during seven endoscopies (all accounted
for by two patients), chest or epigastric pain developing after five endosc
opies, and one tonsillar abrasion. All patients recovered completely, and n
o deaths, perforations, aspiration, or esophageal stricturing resulted from
the procedures.
CONCLUSIONS: A rigorous, systematic endoscopic biopsy protocol in patients
with Barrett's esophagus does not produce esophageal perforation or bleedin
g when performed by an experienced team of physicians, nurses, and technici
ans. (C) 2000 by Am. Cell. of Gastroenterology.